Canakinumab is a biologic medicine used to treat certain autoinflammatory diseases, such as systemic juvenile idiopathic arthritis (sJIA) and cryopyrin-associated periodic syndromes (CAPS). It is a monoclonal antibody that targets and neutralizes interleukin-1β, a substance in the body that causes inflammation. It works by reducing the amount of interleukin-1β in the body, which helps reduce symptoms of inflammation. Canakinumab is usually given as an intravenous (IV) infusion every 8 weeks.
Canakinumab, sold under the brand name Ilaris, is a medication used to treat several autoinflammatory conditions in adults and children. Here's a breakdown of its mechanism of action and uses:
What are autoinflammatory conditions?
Autoinflammatory conditions are a group of diseases characterized by chronic (long-lasting) inflammation caused by the body's immune system attacking its own tissues.
How does Canakinumab work?
- Canakinumab belongs to a class of drugs called interleukin-1 beta (IL-1β) inhibitors. IL-1β is a protein involved in the inflammatory response.
- Canakinumab works by blocking the activity of IL-1β, thereby reducing inflammation throughout the body.
What is Canakinumab used for?
Canakinumab is approved for the treatment of various autoinflammatory conditions, including:
- Cryopyrin-associated periodic syndromes (CAPS): This group of rare genetic disorders causes episodes of fever, rash, joint pain, and other inflammatory symptoms.
- Tumor necrosis factor receptor associated periodic syndrome (TRAPS): This rare genetic disorder causes recurring episodes of fever, rash, and inflammation in various body parts.
- Hyperimmunoglobulin D syndrome (HIDS)/Mevalonate kinase deficiency (MKD): This rare genetic disorder causes recurrent fevers, abdominal pain, and other inflammatory symptoms.
- Familial Mediterranean fever (FMF): This inherited condition causes recurrent episodes of fever, severe abdominal pain, and inflammation in other body parts.
- Still's disease: This rare inflammatory condition can affect both adults and children, causing fever, joint pain, rash, and other symptoms.
- Gouty arthritis: Canakinumab is also used in some cases to treat acute gout flares, which are sudden attacks of severe joint pain, swelling, and redness.
Important points to remember:
- Canakinumab is administered as an injection under the skin by a healthcare professional. The frequency of injections depends on the specific condition being treated.
- Canakinumab can have side effects. Common side effects include infections (colds and upper respiratory tract infections), abdominal pain, and injection-site reactions. More serious side effects are possible but less common.
- Canakinumab is not a cure for any of the conditions it treats. It helps manage the symptoms and reduce the frequency and severity of flares.
- Canakinumab is a prescription medication and should only be used under the supervision of a healthcare professional. They can assess if Canakinumab is appropriate for your specific condition and monitor you for potential side effects.